- Home
- Top 200 Biopharmaceuticals Industry Report (Global)
Top 200 Biopharmaceuticals Industry Report (Global)
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries
- $ 2 488
- Industry report
- by MarketSizeInfo
- June 2013
Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vaccines. The publication provides the market size, growth, and forecasts at the global level ...
Industries: Biopharmaceutical | Countries: World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), Peru, Oman, Iran, North America, Oceania
Antigen Express, Inc. - Product Pipeline Review - 2013
- $ 1 500
- Company report
- by Global Markets Direct
- May 2013
- 26 pages
Antigen Express, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Antigen Express, Inc. - Product Pipeline Review - 2013? provides data on the Antigen Express, Inc.'s research and development focus. The report includes information on current developmental ...
Industries: Biopharmaceutical | Countries: World
TARIS BioMedical, Inc. - Product Pipeline Review - 2013
- $ 1 500
- Company report
- by Global Markets Direct
- May 2013
- 32 pages
TARIS BioMedical, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?TARIS BioMedical, Inc. - Product Pipeline Review - 2013? provides data on the TARIS BioMedical, Inc.'s research and development focus. The report includes information on current developmental ...
Industries: Biopharmaceutical | Countries: World
United Biomedical, Inc. - Product Pipeline Review - 2013
- $ 1 500
- Company report
- by Global Markets Direct
- May 2013
- 24 pages
United Biomedical, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?United Biomedical, Inc. - Product Pipeline Review - 2013? provides data on the United Biomedical, Inc.'s research and development focus. The report includes information on current developmental ...
Industries: Biopharmaceutical | Countries: World
Global Vaccine Market
- $ 652
- Industry report
- by Global Research & Data Services
- May 2013
- 19 pages
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in the world. The study provides essential market information for decision-makers including: - Overall market for vaccines in the world - Market for vaccines by type - Forecasts and ...
Industries: Biopharmaceutical | Countries: World
Crucell N.V. - Strategic SWOT Analysis Review
- $ 125
- Company report
- by Global Data
- May 2013
- 28 pages
Summary Crucell N.V. (Crucell) is a biopharmaceutical company. It discovers, develops, manufactures and markets vaccines and antibodies indicated against infectious diseases. Its product portfolio comprises marketed products, vaccines under development and development stage antibodies. The company's ...
Industries: Biopharmaceutical | Countries: World
NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- May 2013
- 17 pages
Summary NovImmune SA (NovImmune) is a biotechnology company. The company discovers and develops therapeutic monoclonal antibodies for the treatment of immune-related disorders and inflammatory diseases. Its products include NI-0801, NI-0401, NI-0701, NI-0501, NI-1401, NI-0101, NI-1201, NI-1601 and NI-1701. ...
Industries: Biopharmaceutical | Countries: Europe, Switzerland, World
Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- May 2013
- 16 pages
Summary Eiger BioPharmaceuticals, Inc. (Eiger) is a biopharmaceutical company, based in the US. It discovers and develops new antiviral agents against novel targets to treat hepatitis virus infection. The company's product candidates include EBP921, EBP994 and EBP1597. It focuses on the development of ...
Industries: Biopharmaceutical | Countries: United States, World
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
- $ 2 064
- Industry report
- by La Merie Publishing
- May 2013
- 301 pages
Product Description The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobet ...
Industries: Biopharmaceutical | Countries: South Korea, India, China, World
Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)
- $ 645
- Industry report
- by La Merie Publishing
- April 2013
- 94 pages
Product description The Competitive Intelligence Report Erythropoiesis Stimulating Agents (ESA) as of April 2013 provides information on existing first and second generation epoetin products in regulated markets, an overview on biosimilar versions of erythropoietin (EPO) in regulated markets, a compilation ...
Industries: Biopharmaceutical | Countries: World
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- (866) 682 9815
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
